Oncology
A Blood Test Will Not Fix Colorectal Screening by Itself
Freenome’s updated SimpleScreen CRC blood test met primary and secondary endpoints, with improved detection of advanced precancerous lesions. The access promise is real. The policy risk is pretending convenience alone equals prevention.
Biomarker Testing Is Rising, But Eligibility Still Gets Lost
Colon Cancer MRD Testing Is Nearing the Access Threshold
Breast Cancer Blood Tests Could Bring Treatment Decisions Earlier
Lung Cancer Screening Now Has a Diagnostic Bottleneck
Liquid Biopsy Turns Precision Oncology Into an NHS Delivery Test
Molecular Testing Is Europe’s Real Precision Oncology Infrastructure
Cancer Approval Is No Longer Enough
Europe’s Cancer Inequality Map Becomes a Performance Test
Europe’s Cancer Projects Start Looking Like Delivery Infrastructure
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.